Table 4

Cerebrovascular risk factors and their prevalences in patients who received anticoagulation drugs on the basis of TEE findings and the other patients examined

AnticoagulationNo anticoagulation
(n=62) No (%)(n=379) No (%)p ValueOR95% CI
CI, confidence interval; OR, odds ratio.
Men49 (79)210 (55)<0.0013.01.6 to 5.8
Atrial fibrillation26 (42)34 (9.0)<0.0017.34.0 to 13.6
Coronary artery disease24 (39)81 (21)0.0062.31.3 to 4.1
Previous myocardial infarction15 (24)37 (9.8)0.0033.01.5 to 5.8
Valve disease4 (6.5)4 (1.0)0.0166.51.6 to 26.6
Congestive heart failure11 (18)21 (5.5)0.0023.71.7 to 8.1
Hypertension (medication)20 (33)148 (39)NS0.70.4 to 1.3
Hypercholesterolaemia (medication)8 (13)28 (7.4)NS1.90.8 to 4.3
Diabetes16 (26)84 (22)NS1.20.7 to 2.3